Clinical response to onabotulinumtoxina injection therapy for treatment-refractory chronic migraine: "real world" experience

被引：0
|
作者：
Rothrock, J. [1 ]
Andress-Rothrock, D. [1 ]
Hanlon, C. [1 ]
Weibelt, S. [1 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Neurol, Birmingham, AL USA
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-190
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [41] Predictors of Early Positive Response to Treatment of Chronic Migraine With OnabotulinumtoxinA
    Michael, A.
    Michael, D.
    Rothrock, J. F.
    HEADACHE, 2016, 56 : 30 - 31
  • [42] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 74 - 74
  • [43] Real-World Clinical Outcomes of Severe, Treatment-Refractory Chronic Gvhd Patients Treated with Axatilimab Combination Therapies
    Peddireddi, Ayush, V
    Caputo, Jean
    Wall, Sarah A.
    Vasu, Sumithira
    Penza, Sam
    Ho, Kevin
    Esguerra, Vincent
    Kaffenberger, Benjamin
    Choe, Hannah
    BLOOD, 2024, 144 : 7362 - 7363
  • [44] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
    Pınar Yalinay Dikmen
    Seda Kosak
    Elif Ilgaz Aydinlar
    Ayse Sagduyu Kocaman
    Acta Neurologica Belgica, 2018, 118 : 475 - 484
  • [45] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
    Dikmen, Pinar Yalinay
    Kosak, Seda
    Aydinlar, Elif Ilgaz
    Kocaman, Ayse Sagduyu
    ACTA NEUROLOGICA BELGICA, 2018, 118 (03) : 475 - 484
  • [46] Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
    Gago-Veiga, A. B.
    Santos-Lasaosa, S.
    Cuadrado, M. L.
    Guerrero, A. L.
    Irimia, P.
    Lainez, J. M.
    Leira, R.
    Pascual, J.
    Sanchez del Rio, M.
    Viguera, J.
    Pozo-Rosich, P.
    NEUROLOGIA, 2019, 34 (06): : 408 - 417
  • [47] Real-world evidence for chronic migraine control in patients receiving treatment with CGRP mAbs and onabotulinumtoxinA
    Blumenfeld, A.
    Frishberg, B.
    Schim, J.
    Hughes, O.
    Sommer, K.
    Adams, A. Manack
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 152 - 153
  • [48] Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age
    Papetti, Laura
    Frattale, Ilaria
    Ursitti, Fabiana
    Sforza, Giorgia
    Monte, Gabriele
    Ferilli, Michela Ada Noris
    Tarantino, Samuela
    Proietti Checchi, Martina
    Valeriani, Massimiliano
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [49] P058. Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience
    Filippo Baldacci
    Martina Cafalli
    Cinzia Lucchesi
    Sonia Mazzucchi
    Elisa Dini
    Ubaldo Bonuccelli
    Sara Gori
    The Journal of Headache and Pain, 2015, 16
  • [50] OnabotulinumtoxinA Injection Therapy for Chronic Migraine: Influence of Toxin Concentration on Patient Comfort
    Lopez, I
    Rothrock, J. F.
    Weibelt, S.
    HEADACHE, 2012, 52 (05): : 880 - 880
12345